Home
Independent Director
Independent Director
Vice Chairman & M.D.
Whole-time Director
Chairman & Independent Directo
NSE: AUROPHARMA
Share Price
Date | Price (₹) |
---|---|
22 Jan 2025 | 1191.2 |
21 Jan 2025 | 1186.7 |
20 Jan 2025 | 1202.7 |
17 Jan 2025 | 1177.85 |
16 Jan 2025 | 1156.6 |
15 Jan 2025 | 1147.35 |
14 Jan 2025 | 1174.9 |
13 Jan 2025 | 1161.85 |
10 Jan 2025 | 1200.1 |
09 Jan 2025 | 1248.7 |
Market Cap
69,797 Cr
EPS
62.2
P/E Ratio (TTM)
19.1
P/B Ratio (TTM)
2.3
Day’s High
1194.25
Day’s Low
1171.55
DTE
0.3
ROE
11.6
52 Week High
1592.55
52 Week Low
959.05
ROCE
13.7
1M
1Y
3Y
5Y
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
16 Aug 2024
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
16 Aug 2024
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
12 Aug 2024
The approved drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD)
Read more
07 Aug 2024